Biogenomics Limited, a active public limited company, was established on 24 April 2002 in Pondicherry, Pondicherry, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234PY2002PLC009158. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹390.02 Cr and a paid-up capital of ₹383.51 Cr.
Formerly known as Biogenomics Private Limited. It upholds a compliant status. Employing 193 professional, Its leadership includes Pushkar Jauhari (Nominee Director), Rajesh Shashikant Dalal (Director), Rajiv Malik (Additional Director). Past directors included Pushkar Jauhari, Usama Mohamed Ali Al Barwani, Mohamed Ali Mohamed Al Barwani. It holds ₹3.98 Cr open charges and ₹8.70 Cr settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at R. S. No. 139, Manapet Road, Kanniakoil, Manapet Village, Bahour Commune, Pondicherry, Pondicherry, Pondicherry, 607402.
U24234PY2002PLC009158
009158
24 April 2002
₹390.02 Cr
₹383.51 Cr
Roc Pondicherry
Unlisted
Active
Explore comprehensive insights into Biogenomics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pushkar Jauhari | Nominee Director | 19 Jun 2022 | Current |
| Rajesh Shashikant Dalal | Director | 08 Dec 2023 | Current |
| Rajiv Malik | Additional Director | 01 Jul 2025 | Current |
| Namit Rustagi | Director | 28 Mar 2022 | Current |
| Ammar Abdullah Hamad Al Ali | Director | 28 Mar 2022 | Current |
| Archana Rajesh Krishnan | Whole-Time Director | 03 Feb 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Jul 2022 | Past |
| Pramod Abcsdd | Director | 28 Mar 2022 | Past |
| Pramod Abcsdd | Director | 31 May 2022 | Past |
| Pramod Abcsdd | Director | 10 Apr 2010 | Past |
| Pramod Abcsdd | Director | 31 May 2022 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biogenomics Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.48% increase. The company also saw a substantial improvement in profitability, with a 25.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Biogenomics had a promoter holding of 100.00% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹39,840,000.00
₹87,040,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | Standard Chartered Bank | ₹3.98 Cr | Satisfied |
| 11 Jan 2014 | Icici Bank Limited | ₹3.60 Cr | Satisfied |
| 10 Oct 2003 | U.C.O. Bank | ₹1.12 Cr | Satisfied |
Explore comprehensive loan charge details -
Biogenomics has a workforce of 193 employees as of Dec 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenomics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 21 Mar 2024 via Charge ID 100902481 with Standard Chartered Bank was fully satisfied on 20 Aug 2025. was documented.
The activity Rajiv Malik was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2025 & has been associated with this company since 5 months 23 days . was completed.
Progress on Biogenomics Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was documented.
The activity Imran Jamiluddin Shaikh was appointed as a Nominee Director was appointed as a Nominee Director on 20 Aug 2024 & has been associated with this company since 1 year 4 months . was completed.
Progress on Shilpa Rakesh Shetty was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.
Progress on Biogenomics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pondicherry. was documented.
INSUQUICK has been produced with indigenous technology USV and Biogenomics announced the launch of INSUQUICK, India’s first biosimilar Insulin Aspart, which will improve access for people with diabete.
The CIN of Biogenomics Limited is U24234PY2002PLC009158.
Biogenomics Limited is headquartered at R. S. No. 139, Manapet Road, Kanniakoil, Manapet Village, Bahour Commune, Pondicherry, Pondicherry, Pondicherry, 607402.
Biogenomics Limited was incorporated on 24 April 2002.
The current directors of Biogenomics Limited are
The primary industry of Biogenomics Limited is Manufacturing.
Biogenomics Limited is unlisted.
The authorized capital of Biogenomics Limited is ₹390.02 Cr, and the paid-up capital is ₹383.51 Cr.
The compliance status of Biogenomics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX